Indicators

Markets:

News

Latest News about ABCL

Recent news which mentions ABCL

< Previous 1 2 3 4 Next >

Lilly's Antibody Receives FDA Emergency Use Nod For Mild-To-Moderate COVID-19

February 14, 2022

Is It Time to Buy the Nasdaq's 11 Worst-Performing Stocks of 2021?

December 08, 2021

Lilly's COVID-19 Antibody Cocktail Scores FDA Emergency Use For Kids, Including Newborns

December 06, 2021

These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19

November 29, 2021

Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021

November 19, 2021

AbCellera Biologics Inc. (ABCL) Q3 2021 Earnings Call Transcript

November 10, 2021

How Bad Are AbCellera Biologics's Earnings? | Return On Capital Employed

November 09, 2021

Why AbCellera Biologics Stock Sank 21.6% in October

November 04, 2021

Why AbCellera Biologics Stock Jumped 19.4% Last Month

October 07, 2021

AbCellera, Everest Medicines Team Up To Develop 10 Therapeutic Antibodies

September 23, 2021

The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data

September 23, 2021

Cramer's Advice On Ulta Beauty, Laredo Petroleum And More

September 23, 2021

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

September 17, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

September 17, 2021

15 Stocks Moving in Friday's Pre-Market Session

September 17, 2021

AbCellera Stock Is Moving Higher After Expanded Use Nod For Lilly-Partnered COVID-19 Antibody

September 17, 2021

Why AbCellera Biologics Stock Jumped 7% on Wednesday

September 15, 2021

AbCellera Shares Are Moving Higher On Licensing Pact With Moderna

September 15, 2021

Here's Why AbCellera Biologics Stock Gained 10.6% Last Month

September 04, 2021

78 Biggest Movers From Friday

August 16, 2021

Why AbCellera Biologics Stock Was Up More Than 17% on Friday

August 13, 2021

53 Stocks Moving In Friday's Mid-Day Session

August 13, 2021

AbCellera Biologics Inc. (ABCL) Q2 2021 Earnings Call Transcript

August 13, 2021

Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?

August 12, 2021

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

August 12, 2021

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

August 08, 2021

Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: Bloomberg

August 04, 2021

Analyzing AbCellera Biologics's Unusual Options Activity

August 03, 2021

Analyzing AbCellera Biologics's Unusual Options Activity

July 29, 2021

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal

July 28, 2021

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.